INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2010

Vancomycin-plus-gentamicin treatment for infective endocarditis was linked to significant weight gain and risk of obesity.

Researchers compared 48 adults with bacterial infective endocarditis to 48 age-matched controls, evaluating BMI one month prior to symptom onset and one year post-hospital discharge. Patients treated with vancomycin plus gentamicin experienced a significant increase in BMI (+2.3 ± 0.9 kg/m², p = 0.03), whereas controls and patients given other antibiotics did not. Treatment with vancomycin plus gentamicin independently predicted a BMI increase of ≥10% (adjusted OR 6.7; 95% CI 1.37-33.0; p = 0.02), with five patients developing obesity. Weight gain was especially pronounced in males older than 65 who did not undergo cardiac surgery.

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
48 adults with bacterial infective endocarditis and 48 age-matched controls
What was measured
Change in BMI from 1 month before symptoms to 1 year after discharge

THE PAPER

Vancomycin treatment of infective endocarditis is linked with recently acquired obesity.

Thuny F, Richet H, Casalta JP, Angelakis E, Habib G, Raoult D. PLoS One, 2010.

PubMed 20161775 ↗DOI 10.1371/journal.pone.0009074 ↗

Gut & microbiomeNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.